Azilsartan Medoxomil
CAS No: 863031-21-4 Bulkdrugs Directory is a leading API directory that helps you to compare and search azilsartan medoxomil suppliers and manufacturers across the globe.-
Keyword
-
country
-
Date Added
Azilsartan medoxomil is a prodrug that is broken down to azilsartan, which belongs in the angiotensin-receptor blocking (ARB) drug class. It is a selective AT1 subtype angiotensin II receptor antagonist. Azilsartan medoxomil is a relatively recently-developed antihypertensive drug that was first approved by the FDA in February 2011. Many guidelines recommend the use of ARBs as first-line therapy when initiating antihypertensive therapy and indicate that the clinical efficacy of ARBs is comparable to angiotensin-converting enzyme (ACE) inhibitors that are also used as first-line treatment for hypertension. Azilsartan medoxomil is marketed under the brand name Edarbi. It is used to treat hypertension as monotherapy or in combination with other antihypertensive drugs. It is also available in a combination product with [chlorthalidone].
IUPAC Name: (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
CAS No: 863031-21-4
Synonyms: AZILSARTAN MEDOXOMIL
863031-21-4
Edarbi
TAK 491
TAK-491
Azilsartan kamedoxomil
Molecular Formula: C30H24N4O8
Molecular Weight: 568.5 g/mol
We write rarely, but only the best content.
